In his first appearance in a Vioxx trial, the former chief executive of Merck & Co. insisted Thursday that the company was up front about the safety risks of its troubled arthritis drug during his tenure -- despite a jury verdict to the contrary. ... ...
Note: this page has been archived under Muzi Premium Version and is only available to premium members. Please use the Premium Personal Password (PPP) to log in.